How Can We Make Anaphylaxis Less Scary for Patients? (AAN)
Price: FREE for members and non-members
Session recorded on December 7, 2022
Speaker: David Stukus, MD, FACAAI
Viewers can earn credit by completing the posttest questions
This program is a collaboration between the American College of Allergy, Asthma and Immunology and the Allergy and Asthma Network.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Providers
Upon completion of this activity learners should be able to:
1. Improve EBM information on the use of SLIT for single vs multiple allergic patients
2. Improve knowledge on the efficacy and safety profile of single SLIT therapy products available in the USA
3. Integrate SLIT clinical approach in patients with single vs multiple allergens
All identified conflicts of interest have been resolved.
Michael Blaiss, MD, Planner
Disclosures: Consultant: ALK, DBV, Hycor, Merck, Pfizer, Sanofi, Stallergenes Greer, PMD Healthcare
David Stukus, MD, FACAAI, Speaker
Disclosures: Consultant: ARS Pharmaceuticals, Kaleo, Novartis
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance